Vascular endothelial growth factor (VEGF) is a protein important for blood vessels in the kidneys and eyes. Some diseases like diabetes and age-related macular degeneration cause eye disease because of too much VEGF in the eyes. To prevent vision loss in these diseases, ophthalmologists often give an injection in the eye that delivers medicine to lower the amount of VEGF. Sometimes this medicine can be absorbed into the body and travel to the kidneys. This can damage the kidneys and would be a serious side-effect especially in patients who have weakened kidneys. This is a unique study designed to look at a large number of patients at Northwestern to see if indeed there is a pattern of reduced kidney function associated with repeated eye injections of anti-VEGF medicine.
|Effective start/end date||10/1/17 → 9/30/20|
- VitreoRetinal Surgery Foundation (Check #1312 VitreoRetinal Surgery)